• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙裔人群艰难梭菌感染患者严重结局的预测因素

Predictors of severe outcomes in patients with Clostridium difficile infection from a Hispanic population.

作者信息

Paláu-Dávila Laura, Garza-González Elvira, Gutiérrez-Delgado Eva María, Camacho-Ortiz Adrián

机构信息

Servicio de Infectología, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, 64460, Monterrey, Mexico.

Servicio de Gastroenterología, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, 64460, Monterrey, Mexico.

出版信息

Indian J Gastroenterol. 2017 Jan;36(1):38-42. doi: 10.1007/s12664-016-0722-4. Epub 2016 Dec 17.

DOI:10.1007/s12664-016-0722-4
PMID:27987135
Abstract

BACKGROUND

Factors associated with complicated Clostridium difficile infection (CDI) may vary among populations, and predictors of severe outcomes in CDI have not been studied in Hispanic patients. The aim of this study was to identify factors associated with a higher risk of colectomy, all-cause mortality, and CDI-associated mortality in a Hispanic population.

METHODS

We performed a retrospective study of all hospitalized patients with a diagnosis of CDI between January 1, 2011 and September 30, 2015 in a 450-bed teaching hospital in Monterrey, northeast Mexico. Three main outcomes were defined: fulminant colitis with subsequent colectomy, all-cause mortality within 30 days of diagnosis, and CDI-attributable mortality.

RESULTS

Of 261 patients with diarrhea, 176 were diagnosed with CDI. For colectomy, Charlson comorbidity index, ICU stay and mechanical ventilation prior to CDI diagnosis, days with diarrhea prior to treatment, total days of hospital stay and days after CDI diagnosis, elevated ATLAS score, days of diarrhea post CDI treatment, and treatment failure significantly predicted the necessity of surgical treatment with colectomy.

CONCLUSION

Treatment failure, persistent diarrhea, and a high ATLAS score were identified as risk factors for severe outcomes of CDI. A low albumin concentration and high creatinine were associated with higher overall mortality.

摘要

背景

与复杂性艰难梭菌感染(CDI)相关的因素在不同人群中可能有所不同,而西班牙裔患者中CDI严重结局的预测因素尚未得到研究。本研究的目的是确定西班牙裔人群中与结肠切除术、全因死亡率和CDI相关死亡率风险较高相关的因素。

方法

我们对2011年1月1日至2015年9月30日期间在墨西哥东北部蒙特雷一家拥有450张床位的教学医院住院诊断为CDI的所有患者进行了回顾性研究。定义了三个主要结局:暴发性结肠炎伴随后的结肠切除术、诊断后30天内的全因死亡率以及CDI归因死亡率。

结果

在261例腹泻患者中,176例被诊断为CDI。对于结肠切除术,Charlson合并症指数、CDI诊断前的ICU住院时间和机械通气、治疗前腹泻天数、住院总天数和CDI诊断后的天数、升高的ATLAS评分、CDI治疗后腹泻天数以及治疗失败显著预测了结肠切除术手术治疗的必要性。

结论

治疗失败、持续性腹泻和高ATLAS评分被确定为CDI严重结局的危险因素。低白蛋白浓度和高肌酐与较高的总体死亡率相关。

相似文献

1
Predictors of severe outcomes in patients with Clostridium difficile infection from a Hispanic population.西班牙裔人群艰难梭菌感染患者严重结局的预测因素
Indian J Gastroenterol. 2017 Jan;36(1):38-42. doi: 10.1007/s12664-016-0722-4. Epub 2016 Dec 17.
2
Factors predictive of severe Clostridium difficile infection depend on the definition used.艰难梭菌严重感染的预测因素取决于所使用的定义。
Anaerobe. 2016 Feb;37:43-8. doi: 10.1016/j.anaerobe.2015.08.002. Epub 2015 Sep 1.
3
Outcomes following colectomy for Clostridium difficile colitis.艰难梭菌性结肠炎行结肠切除术后的结局
Int J Surg. 2009 Feb;7(1):78-81. doi: 10.1016/j.ijsu.2008.11.002. Epub 2008 Nov 27.
4
Outcome after colectomy for Clostridium difficile colitis.艰难梭菌性结肠炎结肠切除术后的结果。
Dis Colon Rectum. 2004 Oct;47(10):1620-6. doi: 10.1007/s10350-004-0672-2.
5
Evaluation of Rectal Vancomycin Irrigation for Treatment of Infection in Patients Post-Colectomy for Toxic Colitis.经肛门万古霉素灌洗治疗中毒性巨结肠术后感染的评价。
Surg Infect (Larchmt). 2019 Jul;20(5):411-415. doi: 10.1089/sur.2018.265. Epub 2019 Mar 22.
6
Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection.艰难梭菌感染住院成人的流行病学、结局及死亡预测因素
Intern Emerg Med. 2016 Aug;11(5):657-65. doi: 10.1007/s11739-015-1366-6. Epub 2015 Dec 22.
7
Severe complicated Clostridium difficile infection: Can the UPMC proposed scoring system predict the need for surgery?严重复杂性艰难梭菌感染:匹兹堡大学医学中心提出的评分系统能否预测手术需求?
J Trauma Acute Care Surg. 2016 Aug;81(2):221-8. doi: 10.1097/TA.0000000000001112.
8
Trends in Incidence and Outcomes of Clostridium difficile Colitis in Hospitalized Patients of Febrile Neutropenia: A Nationwide Analysis.发热性中性粒细胞减少症住院患者艰难梭菌结肠炎的发病和结局趋势:一项全国性分析。
J Clin Gastroenterol. 2019 Oct;53(9):e376-e381. doi: 10.1097/MCG.0000000000001171.
9
No survival advantage exists for patients undergoing loop ileostomy for clostridium difficile colitis.行回肠袢式造口术治疗艰难梭菌结肠炎的患者不存在生存优势。
Am J Surg. 2019 Jan;217(1):34-39. doi: 10.1016/j.amjsurg.2018.09.023. Epub 2018 Sep 22.
10
Clostridium difficile infection after cardiac surgery: prevalence, morbidity, mortality, and resource utilization.心脏手术后艰难梭菌感染:患病率、发病率、死亡率及资源利用情况
J Thorac Cardiovasc Surg. 2014 Dec;148(6):3157-65.e1-5. doi: 10.1016/j.jtcvs.2014.08.017. Epub 2014 Aug 14.

引用本文的文献

1
Early Prognostic Stratification of Infection in the Emergency Department: The Role of Age and Comorbidities.急诊科感染的早期预后分层:年龄和合并症的作用。
J Pers Med. 2022 Sep 24;12(10):1573. doi: 10.3390/jpm12101573.
2
Clostridium difficile-associated Diarrhea in Developing Countries: A Systematic Review and Meta-Analysis.发展中国家艰难梭菌相关性腹泻:一项系统评价与荟萃分析
Infect Dis Ther. 2019 Mar;8(1):87-103. doi: 10.1007/s40121-019-0231-8. Epub 2019 Jan 18.
3
Hypoalbuminemia as predictor of recurrence of Clostridium difficile infection.

本文引用的文献

1
Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection.晚期慢性肾脏病:艰难梭菌感染的一个强风险因素。
Korean J Intern Med. 2016 Jan;31(1):125-33. doi: 10.3904/kjim.2016.31.1.125. Epub 2015 Dec 28.
2
The challenge of Clostridium difficile infection: Overview of clinical manifestations, diagnostic tools and therapeutic options.艰难梭菌感染的挑战:临床症状、诊断工具和治疗选择概述。
Int J Antimicrob Agents. 2015 Dec;46 Suppl 1:S47-50. doi: 10.1016/j.ijantimicag.2015.11.001. Epub 2015 Nov 3.
3
Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort.
低白蛋白血症作为艰难梭菌感染复发的预测指标。
Wien Klin Wochenschr. 2019 Feb;131(3-4):68-74. doi: 10.1007/s00508-018-1432-y. Epub 2019 Jan 7.
多中心前瞻性队列中艰难梭菌感染并发症的相关因素
Clin Infect Dis. 2015 Dec 15;61(12):1781-8. doi: 10.1093/cid/civ749. Epub 2015 Sep 3.
4
Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis.慢性肾脏病和终末期肾病是艰难梭菌感染不良预后的危险因素:一项系统评价和荟萃分析。
Int J Clin Pract. 2015 Sep;69(9):998-1006. doi: 10.1111/ijcp.12672. Epub 2015 Jul 5.
5
A Multi-Center Prospective Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection.一种用于严重艰难梭菌感染的临床预测工具的多中心前瞻性推导与验证
PLoS One. 2015 Apr 23;10(4):e0123405. doi: 10.1371/journal.pone.0123405. eCollection 2015.
6
Rapid spread of Clostridium difficile NAP1/027/ST1 in Chile confirms the emergence of the epidemic strain in Latin America.艰难梭菌NAP1/027/ST1在智利的迅速传播证实了该流行菌株在拉丁美洲的出现。
Epidemiol Infect. 2015 Oct;143(14):3069-73. doi: 10.1017/S0950268815000023. Epub 2015 Feb 17.
7
Spread of epidemic Clostridium difficile NAP1/027 in Latin America: case reports in Panama.拉丁美洲流行的艰难梭菌 NAP1/027:巴拿马的病例报告。
J Med Microbiol. 2014 Feb;63(Pt 2):322-324. doi: 10.1099/jmm.0.066399-0. Epub 2013 Nov 28.
8
Predicting a complicated course of Clostridium difficile infection at the bedside.预测难辨梭状芽孢杆菌感染的复杂病程。
Clin Microbiol Infect. 2014 May;20(5):O301-8. doi: 10.1111/1469-0691.12391. Epub 2013 Nov 4.
9
Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy.一种简单的临床床边评分(ATLAS)用于预测艰难梭菌感染治疗反应的推导和验证。
BMC Infect Dis. 2013 Mar 25;13:148. doi: 10.1186/1471-2334-13-148.
10
Isolation of a toxigenic and clinical genotype of clostridium difficile in retail meats in Costa Rica.哥斯达黎加零售肉类中产毒和临床基因型艰难梭菌的分离。
J Food Prot. 2013 Feb;76(2):348-51. doi: 10.4315/0362-028X.JFP-12-169.